Dr. Joel Ross, the New Jersey geriatrician and clinical researcher behind trials of earlier Alzheimer''s therapies, on what anti-amyloid drugs actually change in everyday care.

Mitral regurgitation is one of the most common heart valve conditions worldwide. For much of modern medicine, patients with severe mitral regurgitation had relatively few treatment options. If the ...

For a long time the extent of sobriety tech was a simple counter that told you how many days you'd gone without a drink. That's changed. A new wave of recovery apps now blends habit tracking, peer ...

Atrial fibrillation raises the lifetime risk of stroke roughly fivefold, and for decades, physicians have relied on anticoagulants to lower that risk. Warfarin eventually gave way to direct oral ...